Neoantigens Neoepitope peptides, a critical component in the burgeoning field of cancer immunotherapy, represent specific peptide fragments derived from mutated proteins within cancer cells. These altered peptides, when presented by Major Histocompatibility Complex (MHC) molecules on the surface of tumor cells, can be recognized by the immune system, specifically T cells, as foreign.作者：HR Gurung·2024·被引用次数：41—Several neoantigen-directed therapies require the presentation ofneoepitopes—8–11 amino acid peptidesderived from mutated proteins—by ... This recognition is the foundation for mounting an anti-cancer immune response, making neoepitope peptides a focal point for developing personalized cancer vaccines and therapies. Understanding their nature, identification, and application is paramount for advancing cancer treatment.
At their core, neoepitopes are a class of MHC-bound peptides that act as antigenic determinants of neoantigens. Neoantigens themselves are novel antigens that arise from genetic mutations within tumor cells, distinguishing them from normal cellular proteinsNeo-epitope Peptides as Biomarkers of Disease .... These mutations can lead to altered amino acid sequences, resulting in the generation of unique peptides that are not found in healthy tissues.作者：HR Gurung·2024·被引用次数：41—Several neoantigen-directed therapies require the presentation ofneoepitopes—8–11 amino acid peptidesderived from mutated proteins—by ... When these mutated peptides are processed and presented by MHC molecules, they signal to the immune system that something is amiss within the cell. This process is fundamental to immune surveillance, and in the context of cancer, it offers a powerful avenue for therapeutic interventionSystematic discovery of neoepitope–HLA pairs for .... The identification and synthesis of these specific neoepitope peptides are crucial for harnessing the body's own immune defenses against cancer.作者：D Jiang·2024·被引用次数：16—NeoaPred: a deep-learning framework for predicting immunogenic neoantigen based on surface and structural features of peptide–human leukocyte antigen complexes ...
The primary interest in neoepitope peptides stems from their potential in personalized cancer immunotherapy998 Identification and expansion of neoantigen-specific .... Unlike traditional cancer treatments that target broad cellular processes, therapies focused on neoepitopes aim to specifically elicit an immune response against the unique mutations present in an individual's tumorThis product is for research use only andis not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from .... This personalized approach holds the promise of greater efficacy and reduced side effects.
Several applications highlight the importance of neoepitope peptides:
* Personalized Cancer Vaccines: Neoantigen-based personalized cancer vaccines are designed by identifying the specific neoepitopes present in a patient's tumor. These vaccines then aim to train the patient's immune system to recognize and attack cells expressing these particular neoepitopes. This often involves synthesizing customized peptide libraries or long peptides that encompass these neoepitopes.
* Immune Monitoring: Overlapping neo-epitope spanning peptide libraries, pools, and arrays serve as efficient tools for monitoring both humoral and cellular immune responses. This allows researchers and clinicians to assess the effectiveness of immunotherapies and track the development of anti-tumor immunity.作者：S Morisaki·2023·被引用次数：7—We encountered cases where the longpeptidealso contained aneoepitopewith a strong affinity for class I, resulting in high efficacy and ...
* Enrichment and Expansion of Immune Cells: Neoepitope peptides can be used to isolate and expand specific immune cells, such as CD8+ T cells, that are capable of recognizing tumor-specific antigens. This process can enhance the patient's immune repertoire against their cancer.作者：TW Hulett·2016—We designed a 15-merpeptidearray of mutated and nativepeptidesfrom the murine mammary carcinoma 4T1 and used it to characterize the serum ...
The identification of neoepitope peptides is a complex but vital step in developing targeted therapiesPepTracR: a Centralized Database for Pathogen Peptides .... This process typically involves analyzing the tumor's genetic mutations, predicting potential neoantigens, and then determining which of these neoantigens will be presented as peptides by MHC moleculesCustom cancer neoepitope microarrayUp to 5500 different custom peptidesUp to 2750 wt/mutant peptide pairs Incl. polio and HA control peptides.. Computational tools and bioinformatics frameworks, such as NeoaPred, are increasingly employed to predict immunogenic neoantigens based on various features of peptide-MHC complexes.
Once identified, neoepitope peptides can be synthesized for therapeutic use.Neoantigen-based personalized cancer vaccines: the emergence of ... This can range from short peptides of 8-11 amino acids to longer peptide constructs998 Identification and expansion of neoantigen-specific .... The synthesis of these custom peptides is a specialized area, with companies offering services for generating large numbers of different custom peptides, including weight/mutant peptide pairs for comparative analysis. Peptide purity and accurate synthesis are critical for ensuring the efficacy and safety of these therapeutic agents. It's important to note that many of these synthesized peptides are for research use only and are not approved for human clinical diagnosis.
Despite the immense promise, challenges remain in the field of neoepitope peptide research and application.作者：A Arvanitidis·2016·被引用次数：12—Neoepitope peptide biomarkershold great potential in this respect as, they have been successful in characterizing localized pathological ... One significant hurdle is the potential for neoepitopes to arise from altered self-peptides, which can lead to thymic deletion and tolerization, where the immune system is trained to ignore these altered peptides.作者：HR Gurung·2024·被引用次数：41—Several neoantigen-directed therapies require the presentation ofneoepitopes—8–11 amino acid peptidesderived from mutated proteins—by ... Strategies are being developed to overcome this immune tolerance and boost T cell recognition.
Furthermore, predicting the immunogenicity of neoepitopes—their ability to elicit a strong immune response—is an ongoing area of research.Neoantigen-based personalized cancer vaccines: the emergence of ... Factors such as binding affinity to MHC molecules, the specific amino acid sequence, and the surrounding cellular environment all play a role. Developing robust models and assays to accurately predict immunogenicity is crucial for selecting the most effective neoepitopes for therapeutic intervention.
The field is rapidly evolving, with ongoing research exploring new methods for neoepitope discovery, synthesis, and therapeutic application. As our understanding deepens and technologies advance, neoepitope peptides are poised to play an increasingly significant role in the fight against cancer, offering a more precise and potentially more effective path to remission and long-term survival作者：CA Brennick·2017·被引用次数：87—Sinceneoepitopes arise from altered self-peptides, neoepitope-specific T cells potentially face thymic deletion and tolerization. This issue was addressed ....
Join the newsletter to receive news, updates, new products and freebies in your inbox.